Skip to main content
hello world

Avicanna: Top 10 Undervalued Healthcare Sector Stocks on TSX (AVCN)

AI-generated - The Globe and Mail - Tue Jul 23, 8:00PM CDT

Avicanna is now ranked among the top 10 undervalued stocks in the Healthcare sector on the Toronto Stock Exchange.

  • A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
  • Valuation methodology provided by Stockcalc (see below)

Stocks in this category are held primarily for capital appreciation.

SymbolNameClose Price ($)Valuation ($)DifferenceAverage Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
ACBAurora Cannabis--- (0.0%)0.00.00.0
AEZSAEterna Zentaris--- (0.0%)0.00.00.0
AIDXHealwell AI--- (0.0%)0.00.00.0
AKUAkumin--- (0.0%)0.00.00.0
APLIAppili Therapeutics--- (0.0%)0.00.00.0
APSAptose Biosciences--- (0.0%)0.00.00.0
AVCNAvicanna--- (0.0%)0.00.00.0
AVNTAvant Brands--- (0.0%)0.00.00.0
BCTBriaCell Therapeutics--- (0.0%)0.00.00.0
BHCBausch Health Companies--- (0.0%)0.00.00.0

All data provided as of July 23, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.

Avicanna

Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District.

Avicanna is listed under AVCN on the Toronto Stock Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.

Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:

  • Discounted Cash Flow (DCF)
  • Price & Other Comparables
  • Multiples
  • Adjusted Book Value (ABV)
  • Analyst Consensus

Artificial Intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.